Strikingly, 92% of oligodendrogliomas harbored active TERTp mutations, compared to 12.2% in astrocytomas, thus highlighting mutual exclusivity between ATRX and TERTp alterations. This evidence concerns the gene ATRX and astrocytoma (excluding glioblastoma).